Read + Share
Amedeo Smart
Independent Medical Education
Lynce F, Stevens LE, Li Z, Brock JE, et al. TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer. Breast Cancer Res 2024;26:20.PMID: 38297352
Email
LinkedIn
Facebook
Twitter
Privacy Policy